14 Results for "

RIPOR2

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "RIPOR2" in MCE Product Catalog:

7
7 Publications Verification
Referencia número: HY-100339
No. CAS: 1346547-00-9
Pureza:  99.93%
Target:  

RIP kinase

Áreas de investigación:  

Endocrinology

GSK583 is a highly potent, orally active and selective inhibitor of RIP2 Kinase, with IC50 of 5 nM. GSK583 inhibits both TNF-α and IL-6 production with an IC50 value of 200 nM.
2
2 Cited Publications
Referencia número: HY-112038A
Pureza:  98.82%
Target:  

RIP kinase

Áreas de investigación:  

Inflammation/Immunology

GSK2983559 is an orally active and potent receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 blocks many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples .
2
2 Cited Publications
Referencia número: HY-112038
No. CAS: 1579965-12-0
Pureza:  99.90%
Target:  

RIP kinase

Áreas de investigación:  

Inflammation/Immunology

GSK2983559 free acid (compound 3) is an orally active and potent receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 free acid can block many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples .
2
2 Cited Publications
Referencia número: HY-19761
No. CAS: 1581270-11-2
Target:  

RIP kinase

Áreas de investigación:  

Cancer

RIP2 kinase inhibitor 2 is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043437 A1, compound example 9.
1
1 Cited Publications
Referencia número: HY-19764
No. CAS: 1423186-80-4
Target:  

RIP kinase

Áreas de investigación:  

Cancer

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.
Referencia número: HY-N0600
No. CAS: 62025-50-7
Ginsenoside F3 is a saponin extracted from the leaves of Panax ginseng with immunoenhancing and antitumor immunostimulatory activities. Ginsenoside F3 upregulates RIPOR2 with a Kd value of 3.77 μM. Ginsenoside F3 enhances NF‑κB activation, upregulates T‑bet and downregulates GATA‑3, increases the production of IL‑2 and IFN‑γ, decreases the production of IL‑4 and IL‑10, reverses CD8⁺ T‑cell exhaustion, restores cytokine secretion, and enhances antitumor immunity in a mouse non‑small cell lung cancer model. Ginsenoside F3 can be used for the research of non-small cell lung cancer [2].
Referencia número: HY-111870
No. CAS: 2089205-64-9
Pureza:  99.97%
Target:  

PROTACs RIP kinase

Áreas de investigación:  

Cancer

PROTAC RIPK degrader-6 (example 1) is a Cereblon-based PROTAC targeting RIP Kinase degradation wherein the RIP2 kinase inhibitor is linked via a linker to a cereblon binder .
Referencia número: HY-RS12002
Áreas de investigación:  

Others

RIPOR2 Human Pre-designed siRNA Set A contains three designed siRNAs for RIPOR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Referencia número: HY-136010
No. CAS: 2126803-41-4
Target:  

RIP kinase PROTACs

Áreas de investigación:  

Inflammation/Immunology

RIP2 Kinase Inhibitor 4 is a potent and selective RIPK2 PROTAC. RIP2 Kinase Inhibitor 4 effectively degrades RIPK2 (pIC50 of 8) and inhibits the release of related TNF-α .
Referencia número: HY-133014
No. CAS: 2380028-10-2
Target:  

RIP kinase

Áreas de investigación:  

Inflammation/Immunology

RIP2 kinase inhibitor 1 (compound 11) is a potent and selective receptor interacting protein 2 (RIP2) kinase inhibitor with an IC50 of 0.03 μM for RIP2 FP. RIP2 kinase inhibitor 1 is used for autoinflammatory disorders .
Referencia número: HY-147235
No. CAS: 2143956-20-9
Target:  

RIP kinase PROTACs

Áreas de investigación:  

Infection

RIPK2-IN-2 (example 25) is a RIP2 kinase PROTAC inhibitor. RIPK2-IN-2 can block RIP2-dependent proinflammatory signaling, regulated RIP2 kinase activity in auto inflammatory diseases .
Referencia número: HY-112907
No. CAS: 1398053-50-3
Pureza:  99.76%
Target:  

RIP kinase

Áreas de investigación:  

Inflammation/Immunology

RIP2 Kinase Inhibitor 3 is a highly potent and selective inhibitor of receptor interacting protein-2 (RIP2) Kinase with an IC50 of 1 nM .
Referencia número: HY-118316
No. CAS: 899758-61-3
Áreas de investigación:  

Inflammation/Immunology

GSK223 is a quinazolinone NOD1 pathway inhibitor with potential anti-inflammatory activity. GSK223 can selectively inhibit IL-8 release under iE-DAP stimulation without affecting IL-8 secretion caused by TNF receptor, TLR2 or NOD2 agonists. GSK223 does not directly inhibit RIP2 kinase activity.
Referencia número: HY-100339R
No. CAS: 1346547-00-9
Áreas de investigación:  

Endocrinology

GSK583 (Standard) is the analytical standard of GSK583 (HY-100339). This product is intended for research and analytical applications. GSK583 is a highly potent, orally active and selective inhibitor of RIP2 Kinase, with IC50 of 5 nM. GSK583 inhibits both TNF-α and IL-6 production with an IC50 value of 200 nM.
  • 1